by Mollie McDowell | May 19, 2014 | Rock Weekly
Last week, after a Brookings Institution study declared that the US has become less entrepreneurialover time, we also heard of an impending seven year lull in technology breakthroughs. No need to panic: here’s what digital health VCs are most excited about and why the...
by Mollie McDowell | May 12, 2014 | Rock Weekly
May 12, 2014 We polled 100 investors on what will be the next digital health IPO and this is what they said. Send us your vote here. We got a few surprises last week, as Facebook shirked Moves’ previous privacy promises, and everyone was flaunting the discovery of the...
by Mollie McDowell | May 5, 2014 | Rock Weekly
Healthcare economics dominated the airwaves, as CMS proposed to cut payments for hospital readmissions and rallied for even more hospital transparency. Also, it came out that exchange enrollment exceeded its goal – just not in the way it needed to. In hardware...
by Mollie McDowell | Apr 28, 2014 | Rock Weekly
As Facebook acquired Moves, quantified selfers continued to ask what Nike FuelBand’s demise means for Fitbit, Jawbone, and anything else on your wrist. Beyond wearables, a new FDA proposal may give products targeting high-risk medical conditions a fast track to...
by Mara Perman | Apr 21, 2014 | Rock Weekly
The rumor of Nike killing its FuelBand product started on Secret and quickly spilled into a reported story, soliciting a finely-worded response from the athletic wear giant. Our take: FuelBand is dead, either way. If Nike goes looking for a new business to enter, 9...
by Mollie McDowell | Apr 14, 2014 | Rock Weekly
In case you missed the news last week, our portfolio companies dominated the funding charts, including drchrono, Wellframe, and Andreessen Horowitz’s first major health investment — Omada Health. However, Beltway Insiders had a particularly rough week. HHS got a new...
Recent Comments